Clinical Development Innovation: Decentralised Trials, AI-Optimised Protocol Design, and Real-Time Analytics

The full version of this content, along with thousands of articles and analysis reports, can be found here: Clinical Development Innovation: Decentralised Trials, AI-Optimised Protocol Design, and Real-Time Analytics

The economics of drug development remain unforgiving. Despite decades of scientific progress, the average timeline from first-in-human dosing to regulatory approval still spans close to a decade, while the fully loaded cost per approved asset frequently exceeds £1.5 billion when accounting for attrition. Phase III failure rates remain stubborn, protocol complexity has risen, and site-level […]

This content was published by Platform Executive. If you enjoy the content then please post a link, or share on social media to help us.



Clinical Development Innovation: Decentralised Trials, AI-Optimised Protocol Design, and Real-Time Analytics posted first on https://www.platformexecutive.com/

Comments

Popular posts from this blog

New York directs two cryptocurrency lending platforms to cease activity

China drafts new data measures, defines “core data”

European Union tells ‘Big Tech’ to extend fake news watch